Understanding the Venice Classification of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a severe condition that can be categorized under the Venice classification into five groups.

• Group 1 encompasses idiopathic or hereditary PAH, often linked to genetic mutations.
• Group 2 includes PAH related to left heart disease, which can stem from conditions like left ventricular dysfunction.
• Group 3 covers PAH associated with lung diseases or hypoxemia, commonly seen in chronic obstructive pulmonary disease (COPD).
• Group 4 involves PAH due to chronic thromboembolic events, where blood clots obstruct the pulmonary arteries.
• Group 5 comprises miscellaneous causes, such as systemic disorders like sarcoidosis or metabolic diseases.

Advances in diagnostics and treatments are crucial for managing these diverse categories effectively.
Understanding the Venice Classification of Pulmonary Arterial Hypertension

Hyperlipidemia

Hyperlipidemia is a family of disorders that are characterized by abnormally high levels of lipids in the blood. This condition is also called hypercholesterolemia or hyperlipoproteinemia. It is a very common disorder, especially in the Western hemisphere, but also throughout the world.

While fats play a vital role in the body’s metabolic processes, high blood levels of fats increase the risk of coronary heart disease (CHD). Hyperlipidemia is a major cause of atherosclerosis and atherosclerosis related conditions like coronary heart disease (CHD), ischemic cerebrovascular disease, peripheral vascular disease and pancreatitis.

The increase in lipids like low density lipoproteins (LDL), cholesterol (esters derivatives) and triglycerides are mainly responsible for this condition. Cholesterol, saturated fat, trans fat in the following food may raise the lipid level in blood:
• Dairy products.
• Ice cream pastries.
• Fried and junk foods.
• Meat

Several other causes of hyperlipidemia
• Obesity.
• Genetic or inheritance.
• Smoking.

Hyperlipidemia can be classified on the basis of lipid type:
*Hypercholesterolemia-In this the level of cholesterol is elevated.
*Hypertriglyceridemia-It is defined as an elevated level of triglycerides.

Hyperlipidemia disease has afflicted humankind since antiquity. Hyperlipidemia is the leading risk factor for cardiovascular diseases. Cholesterol and triglycerides together make it difficult for blood to pass by narrowing the blood vessels.

Complications of hyperlipidemia:
*Atherosclerosis
*Coronary Artery Disease
*Myocardial Infarction
*Angina Pectoris
*Ischemic stroke or Cerebrovascular Accident
Hyperlipidemia

Congenital heart defects

Congenital heart defect (CHD) may be defined as an anatomic malformation of the heart or great vessels which occurs during intrauterine development, irrespective of the age at presentation. Ventricular septal defect and coarctation of the aorta are typical examples of congenital heart defects.

They are the most common congenital birth defects affecting 1–2% of all live births globally with an estimated incidence of 8–10/1000 live births.

Congenital heart defects are serious and common conditions that have significant impact on morbidity, mortality, and healthcare costs in children and adults.

Risk factors contribute to congenital heart defects including:
*Genetic or environmental
*Rubella infection, drugs, heavy drinking during pregnancy
* Women who both have a high BMI
* Gestational diabetes mellitus

Congenital heart defects may be classified into acyanotic (obstructive and left-to right shunt lesions) and cyanotic depending upon whether the patients clinically exhibit cyanosis.

In cyanotic congenital heart defects systemic venous blood bypasses the pulmonary circulation and gets shunted across into the left side of the heart.
Congenital heart defects

Lipoprotein in general

Because lipids, such as cholesterol and triglycerides, are insoluble in water these lipids must be transported in association with proteins (lipoproteins) in the circulation. Large quantities of fatty acids from meals must be transported as triglycerides to avoid toxicity.

The plasma lipoproteins are complexes of lipid and protein which appear as spherical particles when viewed in the electron microscope with negative staining.

These lipoproteins have, in their basic structure, a lipid core to be transported (triacylglycerols (TAG), phospholipids, and cholesterol esters). A hydrophilic layer in which apolipoproteins are embedded thus provides structural stability as well as identity for each type of the lipoprotein.

Plasma lipoproteins are separated by hydrated density; electrophretic mobility; size; and their relative content of cholesterol, triglycerides, and protein into five major classes: from ultra-low-density lipoprotein (ULDL = chylomicrons) to very-low-density lipoprotein (VLDL), intermediate-density lipoproteins (IDL), and high-density lipoproteins (HDL).

Chylomicrons (CM) are the largest in diameter with the lowest density and the highest TAG content. The size of chylomicrons varies depending on the amount of fat ingested.

Lipoprotein lipase (LPL) is an extracellular enzyme that is essential in lipoprotein metabolism.
Lipoprotein in general